Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Patentability of Gene Sequences

This article was originally published in Start Up

Executive Summary

A great deal of confusion has arisen over the statements by Bill Clinton and Tony Blair concerning the patentability of genes and other nucleic acid sequences and the rights of the government to own the results of research which it funds. An inventor funded by the US government is entitled to own and file patent applications on the inventions which results from his research. And patent protection is available in the US for nucleic acid sequences, including genes, ESTs, and partial sequences, and the proteins which these sequences encode, subject to a few well-understood requirements and limitations.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090236

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel